GridAI Technologies (GRDX) Total Liabilities (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Total Liabilities came in at $19.7 million in Q4 2025, down 28.57% YoY from $27.6 million in Q4 2024, and down 56.95% on a QoQ basis from $45.8 million in Q3 2025.
GridAI Technologies (GRDX) Total Liabilities (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Total Liabilities data on file, last reported at $19.7 million in Q4 2025.
- Quarterly Total Liabilities fell 28.57% year-over-year to $19.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $19.7 million (down 28.57% YoY) and the FY2025 annual result came in at $19.7 million, down 28.57% from the prior year.
- Total Liabilities retreated to $19.7 million in Q4 2025, from $45.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $45.8 million in Q3 2025 to a low of $2.6 million in Q3 2023.
- A 5-year average of $15.2 million and a median of $15.6 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities plunged 86.25% — and 2024, when it jumped 741.55%.
- Tracing GRDX's Total Liabilities over 5 years: stood at $19.6 million in 2021, then sank by 86.25% to $2.7 million in 2022, then advanced by 21.6% to $3.3 million in 2023, then jumped by 741.55% to $27.6 million in 2024, then slipped by 28.57% to $19.7 million in 2025.
- The last three Total Liabilities figures came in at $19.7 million (Q4 2025), $45.8 million (Q3 2025), and $29.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 10.03 Bn |
| 10 | GridAI Technologies | 6.06 Mn | 6.06 Mn | - | 19.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.72 Mn |
| Sep 30, 2025 | 45.81 Mn |
| Jun 30, 2025 | 29.68 Mn |
| Mar 31, 2025 | 28.74 Mn |
| Dec 31, 2024 | 27.61 Mn |
| Sep 30, 2024 | 15.77 Mn |
| Jun 30, 2024 | 15.49 Mn |
| Mar 31, 2024 | 13.27 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 2.65 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | 2.82 Mn |
| Dec 31, 2022 | 2.70 Mn |
| Sep 30, 2022 | 6.93 Mn |
| Jun 30, 2022 | 18.12 Mn |
| Mar 31, 2022 | 18.07 Mn |
| Dec 31, 2021 | 19.61 Mn |
| Sep 30, 2021 | 19.39 Mn |
| Jun 30, 2021 | 6.74 Mn |
| Mar 31, 2021 | 3.58 Mn |